Abstract 14687: Achieved Eicosapentaenoic Acid (EPA) Levels Predicts Regression of Coronary Plaque Volumes by Coronary Computed Tomography Angiography (CCTA) in the EVAPORATE Trial

Suvasini Lakshmanan,Chandana Shekar,April Kinninger,Ilana Golub,Suraj Dahal,Divya Birudaraju,Lavanya Cherukuri,Vahid Rezvanizadeh,Sajad Hamal,Khadije Ahmad,Sion K. Roy,John Nelson,Deepak L. Bhatt,Matthew J. Budoff

Abstract 14687: Achieved Eicosapentaenoic Acid (EPA) Levels Predicts Regression of Coronary Plaque Volumes by Coronary Computed Tomography Angiography (CCTA) in the EVAPORATE Trial

2020

Suvasini Lakshmanan
Chandana Shekar
April Kinninger
Ilana Golub
Suraj Dahal
Divya Birudaraju
Lavanya Cherukuri
Vahid Rezvanizadeh
Sajad Hamal
Khadije Ahmad
Sion K. Roy
John Nelson
Deepak L. Bhatt
Matthew J. Budoff

Background: Despite the beneficial effects of statins on progression of coronary atherosclerosis and cardiovascular (CV) events, significant CV risk persists in patients with hypertriglyceridemia. ...

Keywords:

beneficial effects
Cardiology
Hypertriglyceridemia
Internal medicine
Medicine
in patient
Eicosapentaenoic acid
coronary plaque
coronary computed tomography angiography
coronary atherosclerosis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations